Brief: HLS Therapeutics reports Q2 results
11/08/2022 11:47
Aug 11 (Reuters) - HLS Therapeutics Inc HLS.TO :
* HLS THERAPEUTICS ANNOUNCES Q2 FISCAL 2022 FINANCIAL
RESULTS
* Q2 2022 REVENUE OF $15.5 MILLION
* Q2 2022 NET LOSS WAS $0.28
* Q2 EARNINGS PER SHARE VIEW $-0.08, REVENUE VIEW $16.6
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nCNWL3NlXa
Further company coverage: HLS.TO
Recent news on HLS Therapeutics
See all newsBrief: Hls Therapeutics Increases Normal Course Issuer Bid
Brief: HLS Therapeutics Announces Q2 2026 Financial Results
Canada's HLS Therapeutics Q2 revenue rises on higher cardiovascular drugs demand
Brief: HLS Therapeutics - Secures Nilemdo Reimbursement With Private Payers Covering 80% Of Privately Insured Canadians
Canada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group